Rheumatoid Arthritis Clinical Trials in New York

Showing 1141-1160 of 1,972 trials

Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease

NCT00074035

RATIONALE: Pentostatin may be effective in treating chronic graft-versus-host disease by stopping the immune system from rejecting donor stem cells or donor white blood cells. PURPOSE: This phase II trial is studying how well pentostatin works in treating patients with chronic graft-versus-host disease that is refractory (not responsive) to treatment with steroids.

Graft Versus Host Disease

Alliance for Clinical Trials in Oncology39 participantsStarted Dec 2003

Lewes, Delaware, United States • Newark, Delaware, United States • Chicago, Illinois, United States +13 more locations

COMPLETEDNA< 1 mile

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

NCT00000817

To evaluate the separate and combined efficacy of a standardized acupuncture regimen and amitriptyline on the relief of pain due to peripheral neuropathy and on the quality of life of HIV-infected patients. Both amitriptyline, an antidepressant, and acupuncture, a Chinese medical approach that uses needles to relieve pain, have been used successfully to reduce pain in some people. It is not known how effectively these approaches relieve or reduce pain in patients with peripheral neuropathy secondary to HIV infection.

HIV InfectionsPeripheral Nervous System Disease

National Institute of Allergy and Infectious Diseases (NIAID)260 participantsStarted Nov 1994

San Francisco, California, United States • Denver, Colorado, United States • Washington D.C., District of Columbia, United States +8 more locations

Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

Rheumatoid Arthritis Trials in Other Cities

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant

Early Mobilization Following Volar Locking Plate Fixation of Distal Radius Fractures

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

B Cell Induction in Pediatric Lung Transplantation

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Other Conditions in New York